Expression Vector Market – Global Industry Analysis and Forecast (2022-2029)

Expression Vector Market size was valued at US$ 350.71 Mn in 2021 and the total revenue is expected to grow at 5.5% through 2021 to 2029, reaching nearly US$ 538.23 Mn in the forecast period.

Expression Vector Market Overview:

An expression vector is a plasmid used in the production of insulin in the human body to treat a disease like diabetes. The feature of the expression vector is the origin of replication, a selectable marker, and a suitable site for the insertion of the gene for multiple cloning sites. Hence, an expression vector is a plasmid engineered to introduce a particular gene into target cells. Expression Vector MarketTo know about the Research Methodology :- Request Free Sample Report

Expression Vector Market Dynamics:

The global expression market is growing at a high pace in the forecast period. The growth of the market is attributed to the demand for protein-based drugs. As protein-based drugs are genetically modified versions of human protein to achieve maximum therapeutic output. The high occurrence of chronic diseases and proliferation of genetic diseases is likely to boost the growth of the expression vector market. The development and introduction of the latest biotechnologies in the field of genetics, protein modification, bioinformatics, and molecular biology are the key factors for the growth of the market. Besides, the demand for medical necessities due to the patent expiration of generic drugs in the market is likely to drive the market growth. In addition, growing mergers and collaborations of pharmaceutical industries are likely to fuel the market expansion and hence leading the market growth. For instance, QIAGEN fully acquires the remaining 80% of the market share of NeuMoDx molecular, Inc. a diagnostic instrument company for PCR-based diagnostic automation systems. As a result, the company is building a position in automated molecular testing. The application of expression vector in human insulin production and R&D of biomedical and biopharmaceutical ingredients and products is anticipated to hit the market growth in the forecast period.

Expression Vector Market Segment Analysis:

More than 1L segment is dominating the Type segment of Global Expression Vector Market: The Bacterial vector segment is dominating the type segment of the global expression vector market. The growth of the segment is attributed to a high transformation level and simple transformation protocol. Bacterial vector is an element of the RABV Antigen Delivery System. As bacterial vectors are useful in transporting genetic information into the eukaryotic cells. Due to various innovations and technological development, the applications of bacterial vectors several bacterial vectors have been used for vaccines like HIV vaccines. The mammalian expression vector segment is estimated to grow at a high pace in the expression vector market. The growth of the segment is attributed to the ability of the mammalian vector system to carry out recombinant protein, folding, and post-translational innovations. The Pharmaceutical Industry segment is considered to supplement the growth of the Global Expression Vector Market. Pharmaceutical and biotechnology companies dominated the end-user segment of the Expression vector market with 19.8% of market share and are expected to grow at a high pace during the forecast period. Further, the investment by the pharmaceutical companies in R&D for gene therapies and expression vector applications is likely to lift the growth of the market. In 2019, research and development spending in the pharmaceutical industry was around 186 billion in USD globally. The pharmaceutical and biotechnology sector is more driven by the imperative to manufacturing innovative products and results in spending a significant amount in R&D. Time-limited patent protection of drugs is hitting the market to gear up with the research activities. Hence this factor is likely to boost the growth of the expression vector market. Besides, protein synthesis in the pharmaceutical industry by aiding recombinant DNA technology is a key factor in the expansion of the market. Contract Research Organizations (Cros) & Contract Manufacturing Organizations (Cmos) segment is estimated to grow with significant market share. CROs service is projected to reach USD 86.6 billion by 2027 with a CAGR of 10.7%. Growth in drug and biologics, despite COVID-19, is likely to create more opportunities for the segment.

Expression Vector Market Regional Insights:

Global Expression Vector Market Regional Insights is segmented into North America, Asia Pacific, Europe, Latin America, Middle East, and Africa. North America is leading in the Expression Vector Market with 42.7% of market share in 2020 due to the presence of a major market player like Agilent Technologies. The growth of the region is attributed to wider exposure to technologies and advancement in the research and development sector with high-tech infrastructure. Moreover, mergers and acquisitions are playing an important role in the expression vector market. For example, In September, Agilent Technologies acquire ACEA Bioscience for USD 250 million to increase the presence of the company in cell analysis technologies. Further, In August 2019, Agilent acquired US-based BioTeck Instrument, a nationwide leader of design, manufacturing, and distribution of innovative life science instrumentation for USD 1.165 billion. These mergers and acquisitions are likely to motivate the growth of the market due to the forecast period. Asia Pacific is gaining a significant market share with the highest CAGR of 7.3% during the forecast period. In addition, biotechnology and pharmaceutical companies are driving the growth of the market. Further, the growth of the region is also driven by amplified biotechnological activities with the help of private or government research organizations. Besides growing awareness among the individuals is likely to lift the market expansion. The objective of the report is to present a comprehensive analysis of the Global Expression Vector Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Expression Vector Market dynamics, structure by analyzing the market segments and project the Global Expression Vector Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Expression Vector Market make the report investor’s guide.

Expression Vector Market Scope: Inquire before buying

Global Expression Vector Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US $ 350.71 Mn.
Forecast Period 2022 to 2029 CAGR: 5.5% Market Size in 2029: US $ 538.23 Mn.
Segments Covered: by Type • Bacterial/E.Coli • Mammalian/CHO • Insect/Baculovirus • Yeast
by End-User • Pharmaceutical and Biotechnology Companies • Contract Research Organizations (Cros) & Contract Manufacturing Organizations (Cmos) • Academic Research Institutes
by Host type • Mammalian Expression Vectors • Bacterial Expression Vectors • Insect Expression Vectors • Yeast Expression Vectors • Other Expression Vectors

Expression Vector Market, by Region

North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)

Expression Vector Market Key Player

• Agilent Technologies, Inc. • Thermo Fisher Scientific Inc. • Promega Corporation • Bio-Rad Laboratories • Merck Millipore • QIAGEN • Clontech Laboratories, Inc. • DNA2.0 • New England Biolabs • Sigma-Aldrich Corporation • GenScript USA Inc • GENERAL ELECTRIC

FAQs:

1. What is the global Expression Vector Market share in 2021? Ans: Approximately, 350.71 Million USD. 2. What is the global Expression Vector Market growth? Ans: The global Expression Vector Market is anticipated to grow with a CAGR of 5.5% in the forecast period and is likely to reach USD 538.23 million by the end of 2029. 3. Which End-User segment is expected to dominate the global Expression Vector Market during the forecast period? Ans: The Hospital segment dominated the market with a share of over 38.4% in 2021 and is expected to exhibit the highest CAGR during the forecast period. 4. Which region is expected to dominate the global Expression Vector Market during the forecast period? Ans: North America dominated the Expression Vector Market with a share of over 42.7% in 2021 owing to the larger exposure of research and development activities in the region by biopharmaceutical companies. 5. Who are the key players in the global Expression Vector Market? Ans: Key players of the market include Agilent Technologies, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Merck Millipore, QIAGEN, Clontech Laboratories, Inc., DNA2.0, New England Biolabs, Sigma-Aldrich Corporation, and GenScript USA Inc
1. Global Expression Vector Market: Research Methodology 2. Global Expression Vector Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Expression Vector Market 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Expression Vector Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • South America 3.12 COVID-19 Impact 4. Global Expression Vector Market Segmentation 4.1 Global Expression Vector Market, by Type (2021-2029) • Bacterial/E.Coli • Mammalian/CHO • Insect/Baculovirus • Yeast 4.2 Global Expression Vector Market, by End-User (2021-2029) • Pharmaceutical and Biotechnology Companies • Contract Research Organizations (Cros) & Contract Manufacturing Organizations (Cmos) • Academic Research Institutes 4.3 Global Expression Vector Market, by Host type (2021-2029) • Mammalian Expression Vectors • Bacterial Expression Vectors • Insect Expression Vectors • Yeast Expression Vectors • Other Expression Vectors 5. North America Expression Vector Market(2021-2029) 5.1 North America Expression Vector Market, by Type (2021-2029) • Bacterial/E.Coli • Mammalian/CHO • Insect/Baculovirus • Yeast 5.2 North America Expression Vector Market, by End-User (2021-2029) • Pharmaceutical and Biotechnology Companies • Contract Research Organizations (Cros) & Contract Manufacturing Organizations (Cmos) • Academic Research Institutes 5.3 North America Expression Vector Market, by Host type (2021-2029) • Mammalian Expression Vectors • Bacterial Expression Vectors • Insect Expression Vectors • Yeast Expression Vectors • Other Expression Vectors 5.4 North America Expression Vector Market, by Country (2021-2029) • United States • Canada • Mexico 6. Europe Expression Vector Market (2021-2029) 6.1. European Expression Vector Market, by Type (2021-2029) 6.2. European Expression Vector Market, by End-User (2021-2029) 6.3. European Expression Vector Market, by Host type (2021-2029) 6.4. European Expression Vector Market, by Country (2021-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Expression Vector Market (2021-2029) 7.1. Asia Pacific Expression Vector Market, by Type (2021-2029) 7.2. Asia Pacific Expression Vector Market, by End-User (2021-2029) 7.3. Asia Pacific Expression Vector Market, by Host type (2021-2029) 7.4. Asia Pacific Expression Vector Market, by Country (2021-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Expression Vector Market (2021-2029) 8.1 Middle East and Africa Expression Vector Market, by Type (2021-2029) 8.2. Middle East and Africa Expression Vector Market, by End-User (2021-2029) 8.3. Middle East and Africa Expression Vector Market, by Host type (2021-2029) 8.4. Middle East and Africa Expression Vector Market, by Country (2021-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Expression Vector Market (2021-2029) 9.1. South America Expression Vector Market, by Type (2021-2029) 9.2. South America Expression Vector Market, by End-User (2021-2029) 9.3. South America Expression Vector Market, by Host type (2021-2029) 9.4 South America Expression Vector Market, by Country (2021-2029) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1 Agilent Technologies, Inc. 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2 Thermo Fisher Scientific Inc. 10.3 Promega Corporation 10.4 Bio-Rad Laboratories 10.5 Merck Millipore 10.6 QIAGEN 10.7 Clontech Laboratories, Inc. 10.8 DNA2.0 10.9 New England Biolabs 10.10 Sigma-Aldrich Corporation 10.11 GenScript USA Inc 10.12 GENERAL ELECTRIC
  • INQUIRE BEFORE BUYING